These grants further advance/translate projects with proof of concept and protected IP. Maximum request: $150,000 for one year, 1:1 matching required.
These grants fund partner-led initiatives to advance a partner challenge. Maximum request: $150,000 for one year, with possibility of one year renewal, 1:1 matching required.
These grants offer funding opportunities for clinicians to validate glycomics data from clinical studies. Maximum request: $50,000 for one year.
Partnership Engage Grants are expected to respond to the objectives of the Insight program and the Connection program. However, Partnership Engage Grants cannot respond exclusively to the objectives of the Connection program.
These grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. The small-scale, stakeholder-driven partnerships supported through Partnership Engage Grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. In addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.
Arthur B. McDonald Fellowships recognize early-stage academic researchers in the natural sciences and engineering and support them to enhance their research capacity, so that they can become leaders in their field and inspire others. NSERC awards up to six McDonald Fellowships each year.
If you are an early-stage academic researcher, meaning that you have held an independent academic position for 10 years or less as of June 1 of the year of the competition and currently hold a grant from NSERC, you can prepare a nomination for this award.
An independent academic position is a position that:
A candidate submitting a nomination in June 2021 would have been hired on or after June 1, 2011. The 10-year eligibility window is adjusted to take into account eligible delays in research or periods of inactivity (e.g., due to parental leave, bereavement or illness). For example, a candidate submitting a nomination in June 2021 who took a seven-month parental leave after starting their appointment must have been hired on or after April 1, 2010, in order to be eligible. That is, the eligibility window is increased by two months for every month of eligible delay. For delays related to COVID-19, the eligibility window is also increased by two months for every month of delay. You must identify any such periods in the Delays in research activity section of your personal data form (Form 100), and the impacts of the research delay should be clearly and fully described.
If this award is of interest, please contact Dr. Batia Stolar, Associate Vice-President, Research & Graduate Studies, at avp.research@lakeheadu.ca for more information.
For a Regional Node LOI to be eligible:
In addition to meeting the requirements for the LOI, for a Regional Node Full Application to be eligible:
Note: This funding opportunity seeks a minimum of one participant per Node who self-identifies as Indigenous (First Nations, Inuit or Métis) or provide evidence of having meaningful and culturally safe involvement with Indigenous Peoples in order to:
For the Controlled Trial Application to be eligible:
The specific objective of this funding opportunity are to:
Environment and Climate Change Canada’s Climate Action and Awareness Fund (CAAF) has opened a request for proposals (RFP) for Advancing Climate Change Science and Technology Research.
The RFP will fund up to $59M for projects that will strengthen Canada’s science capacity to understand, identify, accelerate, and evaluate actions towards achieving net-zero greenhouse gas emissions by 2050.
To be eligible for funding under this RFP, lead applicants must be one of the following:
Lead applicants are encouraged to develop collaborative proposals and partner with other academic institutions and organizations, including federal, provincial, territorial, or municipal government partners.
There is a two-step application process, consisting of a Letter of Intent (LOI) phase open to all eligible applicants, followed by an invitation-only full proposal phase. The Applicant Guide and Application Form are attached, however applications will be accepted only through the Grants and Contributions Enterprise Management System. The deadline to submit a LOI is June 10, 2021.
The projects funded by this request for proposals must fall under one of the following themes:
Theme 1: Informing Carbon Sink Enhancements: Nature-Based Climate Solutions
Theme 2: Understanding the Potential for, and Implications of, Negative Emission Technologies
Theme 3: Understanding City- and Municipal-level GHG Emissions and Mitigation Effectiveness
Theme 4: Understanding Multiple Benefits of Integrated Mitigation Approaches for Greenhouse Gases and Air Pollutants
Theme 5: Understanding and Quantifying Transportation Sector Emissions in Canada
For more information, please visit the Climate Action and Awareness Fund webpage.
Applications can be submitted to this competition by institutions, not by individuals. If you are interested in applying to this opportunity, please contact Andrew Hacquoil at ahacquo1@lakeheadu.ca.
The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Epilepsy Research Program (ERP) to understand the mechanisms of post-traumatic epilepsy (PTE) and associated comorbidities to improve quality of life, especially in Service members, Veterans, and caregivers. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
FY21 ERP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
Applications submitted to the FY21 ERP must address one or more of the following Focus Areas below. An application that proposes research outside of the FY21 Focus Areas is acceptable, as long as the applicant provides a strong rationale. The Focus Areas will be mechanism-specific.
o Hardware and/or software platforms that will improve seizure detection, characterization, or diagnosis
o Bioinformatics strategies, to include machine learning, that will improve access, annotation, curation, and visualization of large and novel datasets from single or multiple sources
o Development of new models or better characterization of existing etiologically relevant models for PTE
o Characterization of the circuits involved in PTE
o Validate targets of post-traumatic epileptogenesis or established PTE
o Biomarkers (acute and chronic)
o Treatment
o Prevention
o Comorbidity
o Risk factors such as demographics, genetics, anatomy, pathology, or type of injury
o Outcomes including latency to epilepsy, comorbidities, and mortality
o Pre-existing conditions including psychological and psychiatric risk factors
o Treatment and healthcare outcomes research
o Differentiation of PTE and psychogenic non-epileptic seizures
o Seizure frequency and semiology
o Demographics, genetics, anatomy, pathology, or type of injury
o Comorbidities (e.g., depression, functional deficits, sleep disorders, major illness)
o Latency between type of injury and PTE
o Mortality
o Treatment outcome and healthcare outcome research
o Psychosocial factors
o Neuropsychological dysfunction (cognition and memory)
o Behavioral health (anxiety, depression, post-traumatic stress disorder, impulsivity)
o Reducing stigma
o Activities of daily living
o Reducing healthcare disparities (adjunct programs, support groups, access to care)
o Sleep disorders
o Medication side effects
https://cdmrp.army.mil/funding/erp
Idea Development Award – Letter of Intent due June 14, 2021
Level I: Investigators at or above the level of postdoctoral fellow (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
• Mentor(s) required.
Level II: The Principal Investigator (PI) must be an independent investigator at or above the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
Intent: To solicit novel, innovative research to understand the magnitude and underlying mechanisms of post-traumatic epilepsy (PTE).
• Level I: Applicants can be from any field or discipline and must write the project narrative and other application components, with appropriate guidance from the mentor(s). The mentor(s) must possess qualifications, background, and experience in PTE research.
• Level II is intended to support a more mature, hypothesis-driven research project. Applicants can be from any field or discipline.
Applicants should select one of the Focus Areas below:
• Innovative Research
• Markers and Mechanisms
• Epidemiology
• Longitudinal Studies
While not required, applications to either Funding Level I or II are encouraged to provide relevant preliminary data.
Clinical pharmacologic trials are specifically discouraged.
Level I:
• Maximum funding of $300,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
• Maximum funding of $500,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
Quality of Life Award – Letter of Intent due June 14, 2021
Level I: Investigators at or above the level of postdoctoral fellow (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
• Mentor(s) required.
Level II: The PI must be an independent investigator at or above the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
Intent: To support research that better understands or improves the quality of life and care for individuals living with the symptoms of PTE, as related to the ERP’s mission.
• Level I: Applicants can be from any field or discipline and must write the project narrative and other application components, with appropriate guidance from the mentor(s). The mentor(s) must possess qualifications, background, and experience in PTE research.
• Level II is intended to support a more mature, hypothesis-driven research project. Applicants can be from any field or discipline.
The following Focus Area must be addressed as part of the application:
• Quality of Life
An application that proposes research outside of this Focus Area will be withdrawn.
While not required, applications to either Funding Level I or II are encouraged to provide relevant preliminary data.
Clinical pharmacologic trials are specifically discouraged.
Animal research is prohibited.
Level I:
• Maximum funding of $300,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
• Maximum funding of $500,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
Research Partnership Award – Letter of Intent due June 14, 201
The initiating PI must be an independent investigator at or above the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
Each named Co-PI must be at or above the level of assistant professor (or equivalent) at the time of the application submission deadline.
Intent: To create an avenue for collaborative research partnerships between/among investigators to address a research problem or question in a manner that would be unachievable through separate efforts.
Level I is intended to support preclinical or pre-validation research.
Level II is intended to support research that requires access to a patient cohort for a prospective study and must be the focus of the application.
Applications must include clearly stated plans for interactions between/among the partners. The plans must include communication, decision-making, allocation of resources, coordination of research progress and results, and sharing of data among all investigators and organizations participating in the project.
Applicants should select one of the Focus Areas below:
• Markers and Mechanisms (Funding Level I only)
• Epidemiology (Funding Level I only)
• Longitudinal Studies (Funding Level II only)
Clinical pharmacologic trials are specifically discouraged.
Preliminary data to support the feasibility of the research hypothesis (or hypotheses) or objectives are required.
Level I:
• Maximum funding of $1,300,000 in total costs.
• Maximum period of performance is 3 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
• Maximum funding of $3,100,000 in total costs
• Maximum period of performance is 4 years.
• Indirect costs may be proposed in accordance with the institution’s rate agreement.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the ERP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
help@eBrap.org
Applicant:
Partners:
The Autonomous Vehicle Innovation Network (AVIN)’s WinterTech Development Program will support Ontario SMEs in the mobility space and their partners to validate, test, prototype and demonstrate new products and technologies designed to meet the unique demands of winter weather conditions. WinterTech will leverage the strengths and innovative capabilities of Ontario SMEs in the mobility space and our unique winter weather conditions to establish the province as a testbed for mobility products and services in severe winter weather conditions. Through AVIN’s WinterTech Development Program, Ontario is a global leader in the commercialization of new winter-ready mobility technologies and solutions.
The AV R&D Partnership Fund (Stream 2) contributes up to one-third of eligible project costs for approved projects up to a maximum of $1,000,000, with the remainder contributed by Applicants and/or Partners. Project funding can be used towards the development and demonstration of technologies in the Connected and Autonomous Vehicle (CAV) sector, in the following Priority Areas:
• Mass light vehicles (e.g., cars, trucks and vans)
• Heavy duty vehicles (including commercial vehicles, trucks, buses, RVs and others used for goods movement)
• Transportation infrastructure
• Intelligent Transportation Systems (ITS)
• Transit-supportive systems and vehicles
